Journal of the National Cancer Institute

Press Release
pp. 1487-1487(1)
Author: Sarah L. Zielinski

Press Release
pp. 1487-1487(1)
Author: Sarah L. Zielinski

Press Release
pp. 1487-1487(1)
Author: Sarah L. Zielinski

Ductal Lavage for Early Detection—What Doesn't Come Out in the Wash
pp. 1488-1489(2)
Authors: Carol J. Fabian; Bruce F. Kimler; Matthew S. Mayo

Breast Cancer Screening Comes Full Circle
pp. 1490-1491(2)
Author: Michael Baum

The Gompertzian View: Norton Honored for Role in Establishing Cancer Treatment Approach
pp. 1492-1493(2)
Author: Charles Schmidt

Presidential Candidates Weigh In on Health Issues
pp. 1494-1494(1)

Accelerated Approval Seen as Triumph and Roadblock for Cancer Drugs
pp. 1495-1496(2)
Author: Edward Susman

Stat Bite: Incidence of In Situ and Invasive Breast Cancer by Age, 1975-2001
pp. 1496-1496(1)

Resveratrol May Be a Powerful Cancer-Fighting Ally
pp. 1497-1498(2)
Author: James Schultz

Formation of Pan-European Groups Buoys Cause of Patient Advocates
pp. 1498-1499(2)
Author: Mary Rice

In Brief
pp. 1499-1499(1)
Authors: Kate Travis; Sarah L. Zielinski

Accelerated Approval of Oncology Products: A Decade of Experience
pp. 1500-1509(10)
Authors: Ramzi Dagher; John Johnson; Grant Williams; Patricia Keegan; Richard Pazdur

Ductal Lavage Findings in Women With Known Breast Cancer Undergoing Mastectomy
pp. 1510-1517(8)
Authors: Seema A. Khan; Elizabeth L. Wiley; Norma Rodriguez; Carol Baird; Rathi Ramakrishnan; Ritu Nayar; Michele Bryk; Kevin B. Bethke; Valerie L. Staradub; Judith Wolfman; Alfred Rademaker; Britt-Marie Ljung; Monica Morrow

Reason for Late-Stage Breast Cancer: Absence of Screening or Detection, or Breakdown in Follow-up?
pp. 1518-1527(10)
Authors: Stephen H. Taplin; Laura Ichikawa; Marianne Ulcickas Yood; M. Michele Manos; Ann M. Geiger; Sheila Weinmann; Joyce Gilbert; Judy Mouchawar; Wendy A. Leyden; Robin Altaras; Robert K. Beverly; Deborah Casso; Emily Oakes Westbrook; Kimberly Bischoff; Jane G. Zapka; William E. Barlow

Stroke Risk and Tamoxifen Therapy for Breast Cancer
pp. 1528-1536(9)
Authors: Ann M. Geiger; Glenn M. Fischberg; Wansu Chen; Leslie Bernstein

Effects of Insulin-like Growth Factor Binding Protein-3 and Farnesyltransferase Inhibitor SCH66336 on Akt Expression and Apoptosis in Non–Small-Cell Lung Cancer Cells
pp. 1536-1548(13)
Authors: Ho-Young Lee; Hojin Moon; Kyung-Hee Chun; Yoon-Soo Chang; Khaled Hassan; Lin Ji; Reuben Lotan; Fadlo R. Khuri; Waun Ki Hong

Birth Weight and Risk for Childhood Leukemia in Denmark, Sweden, Norway, and Iceland
pp. 1549-1556(8)
Authors: Lisa Lyngsie Hjalgrim; Klaus Rostgaard; Henrik Hjalgrim; Tine Westergaard; Harald Thomassen; Erik Forestier; Göran Gustafsson; Jon Kristinsson; Mads Melbye; Kjeld Schmiegelow

Treatment of Accidental Intrathecal Methotrexate Overdose With Intrathecal Carboxypeptidase G₂
pp. 1557-1559(3)
Authors: Brigitte C. Widemann; Frank M. Balis; Aiman Shalabi; Matthew Boron; Michelle O'Brien; Diane E. Cole; Nalini Jayaprakash; Percy Ivy; Valerie Castle; Karin Muraszko; Christopher L. Moertel; Robert Trueworthy; Robert C. Hermann; Ali Moussa; Stuart Hinton; Gregory Reaman; David Poplack; Peter C. Adamson

RESPONSE: Re: Are Women More Susceptible to Lung Cancer?
pp. 1560-1561(2)
Authors: William J. Blot; Joseph K. McLaughlin

Re: Are Women More Susceptible to Lung Cancer?
pp. 1560-1560(1)
Authors: Harvey A. Risch; Anthony B. Miller

RESPONSE: Re: Are Women More Susceptible to Lung Cancer?
pp. 1561-1561(1)
Author: Chris Bain